300693 Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses

Other HS 2022 codes under 300693 Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses

• 300610Pharmaceutical goods; sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents, absorbable surgical or dental haemostatics, and surgical or dental adhesion barriers
• 300630Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient
• 300640Pharmaceutical goods; dental cements and other dental fillings, bone reconstruction cements
• 300650Pharmaceutical goods; first aid boxes and kits
• 300660Pharmaceutical goods; chemical contraceptive preparations based on hormones, on other products of heading 2937 or on spermicides
• 300670Pharmaceutical goods; Gel preparations designed to be used in human or veterinary medicine as a lubricant for parts of the body for surgical operations or physical examinations or as a coupling agent between the body and medical instruments
• 300691Pharmaceutical goods; appliances identifiable for ostomy use
• 300692Pharmaceutical goods; waste pharmaceuticals

Frequently asked questions

What is HS 2022 300693?

HS 2022 300693 is "Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses". HS 2022 code 300693 covers "Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses" at level 4 of the HS 2022 hierarchy.

What is the parent category of 300693?

300693 Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses sits under 300693 Pharmaceutical goods; placebos and blinded (or double-blinded) clinical trial kits for a recognised clinical trial, put up in measured doses in the HS 2022 hierarchy.